GlassScriptPhysician profile
Marie Chen
NPI 1811074263
$8,370.02
in general payments reported to CMS, 2019-2025
20 companies · $2,499 in 2025
The $2,499 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $850 · 2022: $1,620 · 2023: $1,375 · 2024: $2,027 · 2025: $2,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,422 · Education: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,422.32 |
| Education | $478.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,088.61 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $944.13 | 2021-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $937.55 | 2021-2025 | Dupixent |
| Genzyme Corporation | $895.57 | 2023-2025 | |
| Galderma Laboratories, L.P. | $677.87 | 2021-2025 | Nemluvio |
| Leo Pharma INC. | $647.85 | 2021-2025 | Adbry |
| Pfizer INC. | $621.05 | 2022-2025 | |
| Lilly USA, LLC | $604.97 | 2022-2025 | Ebglyss, Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $568.32 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $567.39 | 2023-2025 | Tremfya, Simponi, Stelara |
| Ucb, INC. | $174.30 | 2024 | Bimzelx |
| Incyte Corporation | $134.63 | 2023-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $134.12 | 2021 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2024 | |
| Epi Health, LLC | $78.00 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $76.00 | 2025 | Otezla, Otezla |
| Glaxosmithkline, LLC. | $44.93 | 2021-2023 | Shingrix |
| Arcutis Biotherapeutics, INC. | $42.88 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $16.55 | 2025 | |
| Mayne Pharma Commercial LLC | $16.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.